| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.40B | +2.8% |
| Cost of Revenue | $200.3M | +1.5% |
| R&D Expense | $67.4M | -2.2% |
| SG&A Expense | $203.5M | -51.7% |
| Operating Income | $113.6M | -14.3% |
| Interest Expense | $35.3M | -15.1% |
| Pre-tax Income | $93.2M | +24.3% |
| Income Tax | $41.4M | +71.4% |
| Net Income | $63.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $505.9M | -31.4% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $660.2M | +95.5% |
| Current Assets | $1.27B | +6.8% |
| Total Assets | $3.70B | +6.7% |
| Current Liabilities | $899.6M | +108.3% |
| Long-term Debt | $864.3M | -13.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $390.3M | +22.0% |
| Capital Expenditures | $106.6M | -1.9% |
| Investing Cash Flow | -$297.5M | -133.5% |
| Financing Cash Flow | -$321.0M | -179.6% |
| Free Cash Flow | $283.7M | +34.3% |
| +51.9% |
| EPS (Basic) | $1.42 | +59.6% |
| EPS (Diluted) | $1.42 | +59.6% |
| Total Liabilities |
| $1.89B |
| +20.0% |
| Stockholders' Equity | $1.81B | -4.3% |